The DURYSTA market potential seems strong due to the increasing prevalence of glaucoma, the need for long-term, non-adherence-dependent treatments, and its advantage over daily eye drops. With an ...

Over-the-counter treatments are widely available, but ophthalmologists warn the potential side effects can be harmful.